Stratec SE

XTRA:SBS 株式レポート

時価総額：€210.8m

Stratec 将来の成長

Future 基準チェック /36

Stratec利益と収益がそれぞれ年間33.1%と6.3%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に8.2% 35.1%なると予測されています。

主要情報

33.1%

収益成長率

35.12%

EPS成長率

Medical Equipment 収益成長13.5%
収益成長率6.3%
将来の株主資本利益率8.24%
アナリストカバレッジ

Good

最終更新日26 May 2026

今後の成長に関する最新情報

分析記事 • Nov 11

Stratec SE (ETR:SBS) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Stratec SE ( ETR:SBS ) shareholders are probably feeling a little disappointed, since its shares fell 5.2% to €21.75 in...

Recent updates

ナラティブの更新 • May 08

SBS: Lower Growth Assumptions Will Still Allow Future Upside Potential

The analyst fair value estimate for Stratec has been revised from about €26.00 to about €20.00, as analysts trim price targets and factor in lower revenue growth assumptions, softer profit margin expectations, and a higher implied future P/E, in line with recent target cuts from major banks. Analyst Commentary Recent Street research reflects a more cautious stance on Stratec, with price targets revised lower and expectations reset around revenue growth and profitability.
ナラティブの更新 • Apr 21

SBS: Rebased Fair Value And 2025 Margin Guidance Will Define Upside Potential

The analyst price target for Stratec has been cut from about €44.96 to €34.00, as analysts factor in updated fair value, discount rate, growth, margin, and P/E assumptions following recent target revisions from major banks. Analyst Commentary Recent research suggests that while headline price targets for Stratec have come down, some bullish analysts still see potential upside at current levels.
ナラティブの更新 • Apr 06

SBS: Future Upside Will Rely On Reset Margins And Higher P/E

Narrative Update on Stratec The updated analyst price target for Stratec is €28.46, reflecting recent target cuts of up to €12 from prior Street research as analysts factor in a slightly higher discount rate, modestly adjusted profit margin assumptions, and a higher future P/E multiple. Analyst Commentary Recent research commentary on Stratec has focused on recalibrating price targets while keeping an eye on execution risk and the valuation investors are being asked to pay.
ナラティブの更新 • Mar 23

SBS: Future Upside Will Depend On Repriced Earnings Power And Margins

Analysts have trimmed their average price target for Stratec by around €2.40, with recent cuts to €34 helping to explain a slightly lower fair value estimate and modestly softer assumptions for growth, margins and future P/E. Analyst Commentary Recent research revisions on Stratec point to a reset in expectations, with lower price targets feeding into updated views on valuation, execution risk and growth assumptions.
ナラティブの更新 • Mar 09

SBS: Higher Discount Rate And Index Removal Will Still Allow Future Upside

Narrative Update on Stratec The analyst price target for Stratec has been reduced by €1, as analysts reflect slightly adjusted assumptions around discount rates, revenue growth and profit margins in their updated models. Analyst Commentary Bearish analysts trimming their price targets, including the recent €1 reduction, are signaling a more cautious stance on Stratec.
ナラティブの更新 • Feb 22

SBS: Higher Discount Rate Will Still Allow Future Upside Potential

Analysts have reduced their price target on Stratec by €1 to €26, reflecting updated assumptions regarding the company’s discount rate, revenue growth, profit margin and future P/E profile. Analyst Commentary Bearish analysts cutting the price target to €26 are signaling a more cautious stance on Stratec’s risk and reward trade off at current levels.
ナラティブの更新 • Feb 08

SBS: Future Upside Will Rely On Earnings Power And Cost Controls

Narrative update on Stratec Analysts have trimmed their 12 month price target on Stratec by about €1, reflecting updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent research updates on Stratec point to a small pullback in published price targets, with a reduction of about €1 in the latest move and a prior cut from €30 to €27.
ナラティブの更新 • Jan 23

SBS: Future Margin Recovery Will Rely On Efficiency Gains And Cost Controls

Analysts have trimmed their price target on Stratec, with the average moving slightly lower in line with a recent cut from €30 to €27, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent research points to a more cautious stance on Stratec, with the reduced €27 price target reflecting updated views on what analysts see as fair value, the applied discount rate, revenue growth assumptions, margin profile and future P/E expectations.
分析記事 • Jan 10

Returns On Capital Signal Tricky Times Ahead For Stratec (ETR:SBS)

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...
ナラティブの更新 • Jan 08

SBS: Index Exit And 2025 Margin Guidance Will Define Upside Potential

Analysts have trimmed their fair value estimate for Stratec from about €51.00 to roughly €44.96. This aligns with a recent reduction in the Street price target to €27 from €30 as they factor in updated assumptions on discount rates, revenue growth, profit margins, and future P/E multiples.
ナラティブの更新 • Dec 18

SBS: Margin Recovery Outlook Will Support Upside Despite Reduced Price Objective

Analysts have trimmed their price target on Stratec to EUR 27.00 from EUR 30.00, reflecting slightly more cautious assumptions on long term growth, a higher discount rate, and a modestly lower future P E multiple, despite marginally improved margin expectations. Analyst Commentary Bearish analysts have highlighted that the reduction in the price target to EUR 27.00 signals a more guarded stance on Stratec's medium to long term prospects, even as the rating on the shares remains unchanged at Hold.
ナラティブの更新 • Dec 04

SBS: Future Margin Gains Will Emerge As Cost Controls Take Hold

Analysts have modestly reduced their price target on Stratec, trimming it by EUR 3 to EUR 27. This reflects slightly lower long term return expectations while maintaining a cautious stance on the shares.
分析記事 • Nov 29

Stratec (ETR:SBS) Takes On Some Risk With Its Use Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
ナラティブの更新 • Nov 20

SBS: Margins Will Improve With Cost Management And Leadership Changes

The analyst price target for Stratec has been revised downward from €30 to €27. Analysts cited a slightly higher discount rate and modest changes in growth and profitability expectations as key drivers behind the adjustment.
分析記事 • Nov 11

Stratec SE (ETR:SBS) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Stratec SE ( ETR:SBS ) shareholders are probably feeling a little disappointed, since its shares fell 5.2% to €21.75 in...
分析記事 • Nov 07

Investors Give Stratec SE (ETR:SBS) Shares A 35% Hiding

Stratec SE ( ETR:SBS ) shares have had a horrible month, losing 35% after a relatively good period beforehand. The drop...
ナラティブの更新 • Nov 03

SBS: Future Leadership Will Drive Healthcare Diagnostics Forward Amidst Margin Pressures

Analysts have revised their price target for Stratec downward from €36.58 to €33.30, citing expectations of slower revenue growth and a slight decrease in profit margins. What's in the News Tanja Bücherl will join STRATEC SE's Board of Management as Chief Financial Officer effective November 1, 2025.
分析記事 • Sep 23

Getting In Cheap On Stratec SE (ETR:SBS) Might Be Difficult

Stratec SE's ( ETR:SBS ) price-to-earnings (or "P/E") ratio of 25.3x might make it look like a sell right now compared...
ナラティブの更新 • Aug 23

Automation And Digitalization Will Transform Healthcare Diagnostics

Stratec’s consensus price target has been revised downward, primarily reflecting lowered forecasts for both revenue growth and net profit margin, resulting in a new fair value of €37.32. What's in the News Stratec increased its dividend to €0.60 per share for 2024 (previously €0.55), totaling €7.3 million to be distributed.
分析記事 • Jun 17

An Intrinsic Calculation For Stratec SE (ETR:SBS) Suggests It's 34% Undervalued

Key Insights Stratec's estimated fair value is €36.05 based on 2 Stage Free Cash Flow to Equity Stratec is estimated to...
分析記事 • Apr 25

Why We're Not Concerned About Stratec SE's (ETR:SBS) Share Price

With a price-to-earnings (or "P/E") ratio of 30.8x Stratec SE ( ETR:SBS ) may be sending very bearish signals at the...
User avatar
新しいナラティブ • Feb 09

Efficiency Measures And Acquisitions Like Natech Will Boost Future Market Presence

Efficiency measures and cost discipline initiatives could enhance net margins as market conditions stabilize.
分析記事 • Jan 18

An Intrinsic Calculation For Stratec SE (ETR:SBS) Suggests It's 42% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, Stratec fair value estimate is €55.10 Stratec's €32.10 share...
分析記事 • Nov 09

With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Stratec SE ( ETR:SBS ) shares have had a horrible month, losing 25% after a relatively good period beforehand. The drop...
分析記事 • Oct 26

Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
分析記事 • May 11

Here's Why It's Unlikely That Stratec SE's (ETR:SBS) CEO Will See A Pay Rise This Year

Key Insights Stratec to hold its Annual General Meeting on 17th of May Total pay for CEO Marcus Wolfinger includes...
分析記事 • Apr 11

Stratec's (ETR:SBS) Dividend Will Be Reduced To €0.55

Stratec SE's ( ETR:SBS ) dividend is being reduced from last year's payment covering the same period to €0.55 on the...
分析記事 • Apr 01

Stratec SE Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next

Shareholders might have noticed that Stratec SE ( ETR:SBS ) filed its yearly result this time last week. The early...
分析記事 • Mar 28

Stratec (ETR:SBS) Has Announced That Its Dividend Will Be Reduced To €0.55

The board of Stratec SE ( ETR:SBS ) has announced it will be reducing its dividend by 43% from last year's payment of...
分析記事 • Dec 21

Is There An Opportunity With Stratec SE's (ETR:SBS) 36% Undervaluation?

Key Insights Stratec's estimated fair value is €67.40 based on 2 Stage Free Cash Flow to Equity Stratec's €43.00 share...
分析記事 • Nov 03

Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
分析記事 • Oct 19

We Think Stratec (ETR:SBS) Is Taking Some Risk With Its Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 • Jul 12

Return Trends At Stratec (ETR:SBS) Aren't Appealing

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
分析記事 • Jun 27

Stratec SE (ETR:SBS) Shares Could Be 43% Below Their Intrinsic Value Estimate

Key Insights Stratec's estimated fair value is €110 based on 2 Stage Free Cash Flow to Equity Stratec is estimated to...

業績と収益の成長予測

XTRA:SBS - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20282972016314
12/31/20272841818316
12/31/20262671424316
12/31/20252510-170N/A
9/30/202526015322N/A
6/30/202526415726N/A
3/31/2025266172543N/A
12/31/2024258163149N/A
9/30/2024256131834N/A
6/30/2024258171633N/A
3/31/202425212-116N/A
12/31/202327015219N/A
9/30/202325512-22-1N/A
6/30/202326219-31-11N/A
3/31/202326019-515N/A
12/31/202227529-910N/A
9/30/2022270281835N/A
6/30/2022269273755N/A
3/31/2022291403050N/A
12/31/2021287404363N/A
9/30/2021296464063N/A
6/30/2021286412953N/A
3/31/2021266352043N/A
12/31/202025028632N/A
9/30/202023524529N/A
6/30/202022521-420N/A
3/31/202022417-1215N/A
12/31/201921414-621N/A
9/30/201921214N/A8N/A
6/30/201920714N/A13N/A
3/31/201919511N/A9N/A
12/31/201818811N/A12N/A
9/30/201819316N/A20N/A
6/30/201819723N/A28N/A
3/31/201819824N/A28N/A
12/31/201720727N/A30N/A
9/30/201720828N/A30N/A
6/30/201720620N/A21N/A
3/31/201720319N/AN/AN/A
12/31/201618519N/A16N/A
9/30/201616614N/A17N/A
6/30/201615519N/A23N/A
3/31/201614421N/AN/AN/A
12/31/201514722N/A26N/A
9/30/201514722N/A35N/A
6/30/201514621N/A35N/A

アナリストによる今後の成長予測

収入対貯蓄率: SBSは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 1.9% ) よりも高い成長率であると考えられます。

収益対市場: SBS今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: SBS今後 3 年以内に収益を上げることが予想されます。

収益対市場: SBSの収益 ( 6.3% ) German市場 ( 6.7% ) よりも低い成長が予測されています。

高い収益成長: SBSの収益 ( 6.3% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: SBSの 自己資本利益率 は、3年後には低くなると予測されています ( 8.2 %)。

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/05/29 22:12
終値2026/05/29 00:00
収益2025/12/31
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Stratec SE 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11

アナリスト機関
Michael HeiderBerenberg
Jan KochDeutsche Bank
Jan KochDeutsche Bank